Paper6789331
A spectrum of monoclonal antibodies reactive with human mammary tumor cells.
Colcher D and 3 others. Proc Natl Acad Sci U S A, 1981. Cited by 656 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Papers, record 6789331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6789331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records11
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines11
- B72.3Cellosaurus cites the paper3 papers
- B25.2Cellosaurus cites the paper2 papers
- B38.1Cellosaurus cites the paper2 papers
- B50.4Cellosaurus cites the paper2 papers
- B6.2Cellosaurus cites the paper2 papers
- F25.2Cellosaurus cites the paper2 papers
- B14.2Cellosaurus cites the paper1 paper
- B39.1Cellosaurus cites the paper1 paper
- B50.1Cellosaurus cites the paper1 paper
- B84.1Cellosaurus cites the paper1 paper
- F64.5Cellosaurus cites the paper1 paper
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| Antigens, Neoplasm | Major topic |
| Breast Neoplasms | Major topic |
| Liver Neoplasms | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Breast | |
| Clone Cells | |
| Female | |
| Humans | |
| Hybrid Cells | |
| Immunoenzyme Techniques | |
| Immunoglobulin G | |
| Liver | |
| Mice | |
| Mice, Inbred Strains | |
| Radioimmunoassay |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4138143 | Isolation and identification of soluble skin-reactive membrane antigens of malignant and normal human breast cells. | Cancer Res | 1974 | https://conductscience.org/library/papers/4138143 | PubMed |
| 2 | 1172191 | Continuous cultures of fused cells secreting antibody of predefined specificity. | Nature | 1975 | https://conductscience.org/library/papers/1172191 | PubMed |
| 3 | 1255745 | Antigenic cross-reactivity between adenocarcinoma of the breast and fibrocystic disease of the breast. | J Natl Cancer Inst | 1976 | https://conductscience.org/library/papers/1255745 | PubMed |
| 4 | 206905 | Detection in human breast carcinomas of an antigen immunologically related to a group-specific antigen of mouse mammary tumor virus. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/206905 | PubMed |
| 5 | 207421 | Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations. | Cancer Res | 1978 | https://conductscience.org/library/papers/207421 | PubMed |
| 6 | 667938 | Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. | Cell | 1978 | https://conductscience.org/library/papers/667938 | PubMed |
| 7 | 220469 | Human carcinoma-associated precursor antigens of the NM blood group system. | J Surg Oncol | 1979 | https://conductscience.org/library/papers/220469 | PubMed |
| 8 | 221100 | Frequency of association of mammary tumor glycoprotein antigen and other markers with human breast tumors. | Cancer Res | 1979 | https://conductscience.org/library/papers/221100 | PubMed |
| 9 | 378352 | A method for distinguishing benign from malignant breast lesions utilizing antibody present in normal human sera. | Cancer | 1979 | https://conductscience.org/library/papers/378352 | PubMed |
| 10 | 92359 | Ductular carcinoma of the breast: serum antibodies to tumor-associated antigens. | Cancer | 1979 | https://conductscience.org/library/papers/92359 | PubMed |
| 11 | 229294 | Immunologic heterogeneity of tumor cell subpopulations from a single mouse mammary tumor. | J Natl Cancer Inst | 1979 | https://conductscience.org/library/papers/229294 | PubMed |
| 12 | 6999888 | Breast carcinoma-associated antigen. An immunocytochemical study. | Am J Clin Pathol | 1980 | https://conductscience.org/library/papers/6999888 | PubMed |
| 13 | 6935687 | Generation of human monoclonal antibodies reactive with human mammary carcinoma cells. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6935687 | PubMed |
| 14 | 6163523 | Use of monoclonal antibodies to define the diversity of mammary tumor viral gene products in virions and mammary tumors of the genus Mus. | Cancer Res | 1981 | https://conductscience.org/library/papers/6163523 | PubMed |
Cited by115
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 656 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42780573 | Carbohydrate antigen 72-4 and tumor-associated glycoprotein 72 - tumor marker: Past, present and future. | World J Gastrointest Pathophysiol | 2026 | https://conductscience.org/library/papers/42780573 | PubMed |
| 42677388 | From Glycocode to Precision Oncology: Therapeutic Strategies Targeting Aberrant O-GalNAc Glycosylation in Cancer. | Chem Rev | 2026 | https://conductscience.org/library/papers/42677388 | PubMed |
| 42332379 | Comprehensive Profiling Reveals Sialyl-Tn Upregulation and Prognostic Value in Prostate Cancer. | Pathol Int | 2026 | https://conductscience.org/library/papers/42332379 | PubMed |
| 42079341 | Establishment of a Gastric Cancer Diagnostic Model Based on the Combined Evaluation of Peripheral Blood Immune-inflammatory Nutritional Indicators and Tumor Markers. | J Cancer Prev | 2026 | https://conductscience.org/library/papers/42079341 | PubMed |
| 42039398 | Comprehensive profiling reveals Sialyl-Tn upregulation and prognostic value in prostate cancer. | bioRxiv | 2026 | https://conductscience.org/library/papers/42039398 | PubMed |
| 41011249 | Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41011249 | PubMed |
| 40925376 | Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40925376 | PubMed |
| 39346741 | Sialyl-Tn glycan epitope as a target for pancreatic cancer therapies. | Front Oncol | 2024 | https://conductscience.org/library/papers/39346741 | PubMed |
| 38481702 | Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers. | ACS Pharmacol Transl Sci | 2024 | https://conductscience.org/library/papers/38481702 | PubMed |
| 37836876 | Simultaneous Assay of CA 72-4, CA 19-9, CEA and CA 125 in Biological Samples Using Needle Three-Dimensional Stochastic Microsensors. | Sensors (Basel) | 2023 | https://conductscience.org/library/papers/37836876 | PubMed |
| 37728233 | Development and Validation of Tumor Marker Indices in Advanced Gastric Cancer Patients. | Cancer Control | 2023 | https://conductscience.org/library/papers/37728233 | PubMed |
| 37559540 | High-Throughput Sequencing Technology Assisted Investigation of the Correlation Between Intestinal Flora, Serum Biochemistry, Blood Lipids, and Tumour Markers in Patients with Gastric Cancer and Healthy Plateau Residents. | Comb Chem High Throughput Screen | 2024 | https://conductscience.org/library/papers/37559540 | PubMed |
| 37509200 | Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37509200 | PubMed |
| 37305274 | Deciphering Protein O-GalNAcylation: Method Development and Disease Implication. | ACS Omega | 2023 | https://conductscience.org/library/papers/37305274 | PubMed |
| 37284439 | Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens. | Theranostics | 2023 | https://conductscience.org/library/papers/37284439 | PubMed |
| 36713933 | Development of an automated chemiluminescent immunoassay for cancer antigen 72-4 and the evaluation of its analytical performance. | Pract Lab Med | 2023 | https://conductscience.org/library/papers/36713933 | PubMed |
| 36686742 | The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers. | Front Oncol | 2022 | https://conductscience.org/library/papers/36686742 | PubMed |
| 36105678 | Polymeric nanoparticles targeting Sialyl-Tn in gastric cancer: A live tracking under flow conditions. | Mater Today Bio | 2022 | https://conductscience.org/library/papers/36105678 | PubMed |
| 35158915 | Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35158915 | PubMed |
| 34950576 | Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action. | Front Oncol | 2021 | https://conductscience.org/library/papers/34950576 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IVNS1ABP | 10625 | PubTator's text mining | https://conductscience.org/library/genes/10625 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6789331
GET https://conductscience.org/api/papers/v1/6789331/cited_by?page=2